This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

Investor Releases

Date Title View
01 November, 2012 ICON Reports Q3 Revenue of $286 Million, EPS of 29c and Net New Business of $450 Million. (NASDAQ: ICLR) (ISIN:IE0005711209)
05 September, 2012 ICON Forms Strategic Partnership with University College Dublin
24 July, 2012 ICON Reports second quarter 2012 revenue up 19% to $277 million and non-GAAP EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)
20 July, 2012 ICON Shareholders Vote in Favour of All Resolutions at Its Annual General Meeting
12 June, 2012 ICON Announces Peter Gray to Retire from ICON Board of Directors
24 April, 2012 ICON reports a 10% increase in first quarter 2012 revenue to $252m, up 10% year on year, EPS of 15 cents, net new business awards of $385 million and a B:B of 1.5. (NASDAQ:ICLR) (ISIN:IE0005711209)
05 March, 2012 ICON Selected by Roche for Technology Partnership
28 February, 2012 ICON Acquires PriceSpective
16 February, 2012 ICON reports fourth quarter 2011 revenue of $243m, up 5% year on year, and EPS of $0.07. Backlog increases 19%. (NASDAQ:ICLR) (ISIN:IE0005711209)
15 February, 2012 ICON Completes Acquisition of BeijingWits Medical Consulting Ltd
09 January, 2012 ICON Selected by Shire plc's Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services
27 December, 2011 ICON Announces Dr. Anthony Murphy To Retire From Board of Directors
12 December, 2011 ICON Acquires BeijingWits Medical Consulting Ltd
22 November, 2011 ICON plc: Commencement of Share Repurchase Programme
01 November, 2011 ICON Names New Global Head of Clinical Research Services
27 October, 2011 ICON Reports Q3 revenue growth of 7% to $241 million and net new business of $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)
07 September, 2011 ICON Announces Peter Gray To Retire As CEO
30 August, 2011 ICON Selected as a Preferred Provider for Early Phase Clinical Development by Bristol-Myers Squibb
20 July, 2011 ICON Reports Second Quarter 2011 Net New Business of $310 million, Revenue of $233 million and EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)
19 July, 2011 ICON Shareholders Vote in Favour of All Resolutions at Its Annual General Meeting
Displaying 101 - 120 of 272


Search Investor